Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

Studies The Scientist covered this year illustrate the expanding importance of genetic and genomic research in all aspects of life science, from ecology to medicine.

A key mutation turns healing cells into cancer promoters.

From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

Our list of the best and brightest products that 2011 had to offer the life scientist

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

SENSE OF PROPORTION: "more needs to be done relative to the scale of the problem," remarks Stanford ecologist Gretchen Daily. The worldwide spate of emerging and reemerging infectious diseases in the first half of this decade has prompted a growing recognition of the connection between global climate change and human health. Individual researchers from such disparate disciplines as epidemiology and public health, ecology, virology, climatology, nutrition, and biomedicine have directly addresse

Chairman: Arnold Levine, chairman, department of molecular biology, Princeton University Barry Bloom, Weinstock Professor and Howard Hughes Medical Institute (HHMI) investigator, department of microbiology and immunology, Albert Einstein College of Medicine, New York Rebecca Buckley, professor of pediatrics and immunology, Duke University Medical Center Charles Carpenter, chairman, Office of AIDS Research Advisory Committee; professor of medicine,Brown University School of Medicine Don

George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.